Collector
Giriş Yap
Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA | Collector
Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA

Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA

Concord Biotech shares jumped 5.8 per cent on BSE after USFDA cleared Tofacitinib Tablets ANDA

Go to News Site